Mechanisms of HDACs in cancer development

Mechanisms of HDACs in cancer development

Histone deacetylases (HDACs) are a class of epigenetic regulators that play pivotal roles in key biological processes such as cell proliferation, differentiation, metabolism, and immune regulation. Based on this, HDAC inhibitors (HDACis), as novel epigenetic-targeted therapeutic agents, have demonst...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Zhang, Haotian Wang, Zhumei Zhan, Lin Gan, Out Bai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Immunology
Subjects:	histone acetyltransferases histone deacetylases cancer HDACi lymphoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1529239/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enzyme-independent functions of HDAC3 in the adult heart
by: Sichong Qian, et al.
Published: (2025-07-01)

Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01)

Citronellol inhibits the activity of AtSRT1 to increase IAA content and signal transduction, promoting the growth of A. thaliana
by: Jin-Rui Wen, et al.
Published: (2025-02-01)

Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends
by: Huong Anh Mai, et al.
Published: (2025-06-01)

Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
by: Christine Tran, et al.
Published: (2025-02-01)

Preclinical pharmacokinetics and in vitro ADME properties of PAT-1102: a novel HDAC inhibitor for cancer therapy
by: Chandrashekar Mataguru Doreswamy, et al.
Published: (2025-05-01)

Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01)

Short-chain fatty acids: key antiviral mediators of gut microbiota
by: Zhiqiang Xu, et al.
Published: (2025-07-01)

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn’s disease patients
by: Mélissa Chervy, et al.
Published: (2022-12-01)

Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors
by: Julia Krushkal, et al.
Published: (2024-12-01)

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
by: Ibrahim S. Alalhareth, et al.
Published: (2025-02-01)

Histone deacetylases repress the accumulation of licochalcone A by inhibiting the expression of flavonoid biosynthetic pathway-related genes in licorice (Glycyrrhiza inflata)
by: Jiangyi Zeng, et al.
Published: (2025-05-01)

Unlocking the epigenetic code: new insights into triple-negative breast cancer
by: Gowthami Mahendran, et al.
Published: (2024-12-01)

Expression and significance of HDAC5 in oral squamous cell carcinoma
by: HE Fenjun, LIN Fen, CHEN Xueying
Published: (2024-12-01)

HDAC10 and its implications in Sézary syndrome pathogenesis
by: Monika Pieniawska, et al.
Published: (2025-01-01)

The euchromatic histone mark H3K36me3 preserves heterochromatin through sequestration of an acetyltransferase complex in fission yeast
by: Paula R. Georgescu, et al.
Published: (2020-01-01)

Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression
by: Juan Du, et al.
Published: (2025-02-01)

Histone Acetyltransferase MOF-Mediated AURKB K215 Acetylation Drives Breast Cancer Cell Proliferation via c-MYC Stabilization
by: Yujuan Miao, et al.
Published: (2025-07-01)

Design, Synthesis, and Preliminary Antiproliferative Evaluation of 1,2,4-Thiadiazole Derivatives as Possible Histone Deacetylase Inhibitors
by: Rusul Mohammed Hasan Ali, et al.
Published: (2025-02-01)

Epigenetics
by: Ravi Jaiswal, et al.
Published: (2020-01-01)

Histone Deacetylase 6 (HDAC6) in Ciliopathies: Emerging Insights and Therapeutic Implications
by: Zhiyi Wang, et al.
Published: (2025-06-01)

Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer
by: Tingting Qin, et al.
Published: (2025-04-01)

A missense mutation in the Sin3 subunit of Rpd3 histone deacetylase complex bypasses the requirement for FNG1 in wheat scab fungus
by: Huaijian Xu, et al.
Published: (2025-08-01)

Prognostic value of serum HDAC2 and sST2 in occupational asthma patients
by: Ruifeng FENG, et al.
Published: (2024-11-01)

Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest
by: Zhijian Li, et al.
Published: (2025-07-01)

MYST2 histone acetyltransferase promotes lung adenocarcinoma progression by regulating the p38 MAPK signaling pathway
by: Zhiang Huang, et al.
Published: (2025-01-01)

CRISPR activation identifies a novel miR-2861 binding site that facilitates the osteogenesis of human mesenchymal stem cells
by: Seong-Ho Park, et al.
Published: (2024-11-01)

Research advances of histone deacetylases in acute kidney injury
by: Deng Fang-jing, et al.
Published: (2022-04-01)

Effects of Bufexamac, a class IIb HDAC inhibitor, on behavior and neuropathological features in an Aβ-induced rat model of Alzheimer's disease
by: Monireh Mirehei, et al.
Published: (2025-06-01)

HDAC4: an emerging target in diabetes mellitus and diabetic complications
by: Yiqi Lin, et al.
Published: (2025-05-01)

HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01)

Staphylococcus aureus induces mitophagy via the HDAC11/IL10 pathway to sustain intracellular survival
by: Yaji Yang, et al.
Published: (2025-02-01)

The histone acetyltransferase CBP participates in regulating the DNA damage response through ATM after double-strand breaks
by: Wafaa S. Ramadan, et al.
Published: (2025-04-01)

Targeting EP300 in diffuse large b-cell lymphoma: efficacy of A485 and synergistic effects with XPO1 inhibition
by: Yanan Jiang, et al.
Published: (2025-05-01)

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy
by: Rui Han, et al.
Published: (2025-05-01)

Treatment of Sezary syndrome with combination romidepsin and tofacitinib: A case report
by: Sara Suhl, BS, et al.
Published: (2025-01-01)

Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat
by: Tamara Zenz, et al.
Published: (2025-02-01)

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study
by: Beate Vajen, et al.
Published: (2025-05-01)

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies
by: Anna Wawruszak, et al.
Published: (2025-12-01)

Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents
by: Jason H. Gill, et al.
Published: (2025-12-01)